NADP-dependent isocitrate dehydrogenase activity

1. Metabolic syndrome is associated with NADP-dependent isocitrate dehydrogenase activity in humans (MetS: 2.83 ± 0.47 mU/mL; MHO: 4.58 ± 0.67; controls: 6.09 ± 0.93).

   “Serum NADP-dependent IDH enzyme activity was remarkably lower in the MetS group compared to the MHO group as well as to controls”

   HumansMetabolic syndrome compared with metabolically healthy obesity and healthy controlsserum

   Differential NADP-Dependent Isocitrate Dehydrogenases Expression in Metabolically Healthy Obesity vs Metabolic Syndrome: A Probable Predictive Biomarker for Metabolic Deterioration

   The journal of applied laboratory medicine·15 Aug 2025

More on Metabolic syndrome